Was thinking along those lines myself ,, as long as its...

The Company should have Editorial Content prepared and sent with an embargo data / time to
St0ckhe4d
Sm4llc4ps
BioTuesdays
Hot Copper / Market Her4ld

Small video soundbite from Gary ,,, "we are just elated with the results ,, Years in the making to finally achieve Positive Topline Phase II Data"... Rada rada ,, push push then a mention of SNT being a Significant Investment Opportunity.. go team go.... that type of positive push..

SNT 5505 hasnt focused on Symptoms but the reduction of the actual Disease....

Then what would add SUPER VALUE is "Now we will enter discussions with Partners who have already made themselves known to us with regard to advancing the Technology"

Maybe let that one sit for a couple of days to extract the first run on Positive Data then we have Partners ..... to propel the SP and Company value upward and onwards..


You know in this game Phase II is one, if not the largest inflection point during Phase Trialing ,, if SNT don't herald their success you can be 100% sure their competitors wont.. Every non revenueing Biotech is trying to attract Investors and Investor Funds...

Was thinking along those lines myself ,, as long as its announced before open on Monday and not before close on Friday then its a level playing field and no one can take advantage of the Material Information..

Maybe a little teaser with " SNT will be presenting our Top Line Phase II SNT 5505 data in the weekend ahead at a Global Event"?

Certainly from reading the Hashan article and listening to his interview he definitely sees significant value here at SNT ,, so I dare say he will do another Interview,, in fact from looking at the numbers Hashan is doing more PR work for SNT than SNT are doing?

Best of Luck to al invested ,,, Tight Hands required SNT SH need to value their Holdings.....